Chengguang Zhao

Years Active: 2019-2019
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Yangyang Fu, Lihuang Su, Mengsi Cai, Boyang Yao, Sisi Xiao, Qinlian He, Le Xu, Lehe Yang, Chengguang Zhao, Tingting Wan, Lianyou Shao, Liangxing Wang, Xiaoying Huang
Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway. Molecular carcinogenesis 58 (11) (2019)
Hailun Zheng, Lehe Yang, Yanting Kang, Min Chen, Shichong Lin, Youqun Xiang, Caleb Li, Xuanxuan Dai, Xiaoying Huang, Guang Liang, Chengguang Zhao
Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. Molecular carcinogenesis 58 (4) (2019)

Chengguang Zhao.css-eqlu8i{font-size:small;padding-left:4px;}